cheshtasharma

About Cheshta Sharma

This author has not yet filled in any details.
So far Cheshta Sharma has created 1323 blog entries.

Piramal Healthcare Patent Strategy

Healthcare domain till recently has seen establishment of linkages to sell generic drugs by some of the Pharma giant like Piramal Healthcare Group. But ,now the latest trend & the new vision of Pharma Giant likes of Piramal Heathcare group is owning intellectual property & converting it to products.It is speculated that in many [...]

By |2017-09-09T12:05:47+05:30April 23rd, 2012|Patent|0 Comments

Ford’s latest Patent is all about rear seats

Ford is working on a system that makes it easier for back seaters to get in second third row of vehicle. The patent application was filed in UK and details “vehicle 2nd and 3rd row adjustments based on anthropometric characteristics of 2nd and 3rd row rear passenger.” The idea behind the system is to [...]

By |2017-09-07T13:07:49+05:30April 13th, 2012|Patent|0 Comments

Open your Windows to the new world of Safari

Apple’s very own stylish, user friendly web browser with a simplistic interface; Safari. The simple and beautiful user interface makes Safari a favourite amongst all its users. First released in 2003 for MAC, Safari has jumped in great leaps and bounds and recently released its version of Safari 10 for Windows. Safari 10 allows [...]

By |2017-09-09T12:06:57+05:30March 15th, 2012|Patent|0 Comments

Why India is lacking back in Patent Filing ?

Filing of patent applications under WIPO's Patent Cooperation Treaty enables companies to secure patent protection in various countries. It is a measure for knowledge-based economy and a barometer to judge the spread of innovation-based companies in each country. The international patent filings under the WIPO-administered Patent Cooperation Treaty (PCT) reached 1,81,900 applications in the [...]

By |2017-09-07T13:06:44+05:30March 14th, 2012|IP Basics|0 Comments

Compulsory Licensing to NATCO

Overview:The Controller General of Patents, Designs and Trade Marks has given a compulsory license to Hyderabad based Natco a local drug maker to manufacture and sell its generic version of German multinational Bayer’s patent-protected cancer medicine, Nexavar (Sorafenib tosylate), at about 30 times lower than charged by its Bayer Corporation. Detailed Analysis: On Monday [...]

By |2017-09-07T13:05:36+05:30March 14th, 2012|IP Basics, International|0 Comments
Go to Top